| |
| |
|
| Insider
Information: |
Kirk Randal J |
| Relationship: |
10% Owner |
| City: |
Radford |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
3,684,697 |
|
|
Indirect Shares
|
67,796,291 |
|
|
| Direct
Value |
$156,480,702 |
|
|
|
Indirect Value
|
$361,877,979 |
|
|
| Total
Shares |
71,480,988 |
|
|
| Total
Value |
$518,358,681 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
0
|
|
Stock
price went up :
|
6
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 46.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRPO |
Precipio Inc |
10% Owner |
– – • |
2017-06-08 |
4 |
S |
$1.00 |
$1,975,000 |
I/I |
(1,975,000) |
786,613 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-12-04 |
4 |
B |
$2.86 |
$32,890 |
I/I |
11,500 |
792,300 |
1.5 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2014-05-12 |
4 |
B |
$15.89 |
$287,069 |
I/I |
18,066 |
797,360 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2014-05-13 |
4 |
B |
$15.63 |
$500,457 |
I/I |
32,019 |
829,379 |
2.64 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
10% Owner |
– – • |
2006-12-05 |
4 |
B |
$2.84 |
$151,940 |
I/I |
53,500 |
845,800 |
1.5 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-05-17 |
4 |
B |
$4.69 |
$283,886 |
I/I |
60,530 |
858,125 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2017-12-29 |
4 |
A |
$11.33 |
$14,686,410 |
I/I |
1,288,632 |
886,491 |
0 |
- |
|
| PRPO |
Precipio Inc |
10% Owner |
– – • |
2016-01-06 |
4 |
B |
$1.00 |
$4,474,825 |
I/I |
4,474,825 |
894,613 |
1.5 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-05-20 |
4 |
B |
$4.63 |
$1,396,732 |
I/I |
301,670 |
918,459 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-05-21 |
4 |
B |
$4.74 |
$285,457 |
I/I |
60,223 |
930,504 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-05-22 |
4 |
B |
$4.70 |
$541,379 |
I/I |
115,187 |
953,541 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-05-23 |
4 |
B |
$4.67 |
$400,453 |
I/I |
85,750 |
970,691 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-05-24 |
4 |
B |
$4.68 |
$338,972 |
I/I |
72,430 |
985,177 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2021-06-03 |
4 |
A |
$0.00 |
$0 |
I/I |
566,388 |
989,252 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • • |
2011-08-10 |
4 |
B |
$6.13 |
$1,604,031 |
I/I |
261,669 |
1,000,000 |
2.25 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2021-11-23 |
4 |
B |
$3.58 |
$1,741,079 |
I/I |
486,335 |
1,000,000 |
2.25 |
% |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-05-29 |
4 |
B |
$4.68 |
$585,562 |
I/I |
125,120 |
1,010,201 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2022-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,028,089 |
1,015,604 |
0 |
- |
|
| PGEN |
Precigen Inc |
Director |
– • • |
2022-10-05 |
4 |
A |
$0.00 |
$0 |
I/I |
26,374 |
1,015,626 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2003-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
615,050 |
1,048,191 |
|
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-05-30 |
4 |
B |
$4.79 |
$982,237 |
I/I |
205,060 |
1,051,213 |
2.64 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2005-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
1,056,191 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • • |
2006-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
10,800 |
1,066,991 |
0 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-05-31 |
4 |
B |
$4.78 |
$432,246 |
I/I |
90,428 |
1,069,299 |
2.64 |
- |
|
| PGEN |
Precigen Inc |
Chief Executive Officer |
• • • |
2019-06-04 |
4 |
B |
$5.17 |
$233,270 |
I/I |
45,120 |
1,078,323 |
2.64 |
- |
|
271 Records found
|
|
Page 5 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
